Literature DB >> 23430497

Autism spectrum disorder in a child with propionic acidemia.

M Al-Owain1, N Kaya, H Al-Shamrani, A Al-Bakheet, A Qari, S Al-Muaigl, M Ghaziuddin.   

Abstract

Autism is a neurodevelopmental disorder characterized by a combination of reciprocal social deficits, communication impairment, and rigid ritualistic interests. While autism does not have an identifying cause in most of the cases, it is associated with known medical conditions in at least 10% of cases. Although uncommon, cases of autism have also been reported in association with metabolic disorders. In this brief report, we describe the occurrence of autism in a 7-year-old girl with propionic acidemia (PA), a common form of organic aciduria resulting from the deficiency of propionyl-CoA carboxylase and characterized by frequent and potentially lethal episodes of metabolic acidosis often accompanied by hyperammonemia. It is particularly common in countries with high rates of consanguinity. Early diagnosis of autism in patients with metabolic disorders is important since autistic features are sometimes the most disruptive of all the child's problems. This facilitates providing the needed behavioral services not otherwise available for children with metabolic disorders.

Entities:  

Year:  2012        PMID: 23430497      PMCID: PMC3573175          DOI: 10.1007/8904_2012_143

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  23 in total

Review 1.  Genetics of autism: complex aetiology for a heterogeneous disorder.

Authors:  S E Folstein; B Rosen-Sheidley
Journal:  Nat Rev Genet       Date:  2001-12       Impact factor: 53.242

Review 2.  Neurologic considerations in propionic acidemia.

Authors:  John Schreiber; Kimberly A Chapman; Marshall L Summar; Nicholas Ah Mew; V Reid Sutton; Erin MacLeod; Kathy Stagni; Keiko Ueda; Jill Franks; Eddie Island; Dietrich Matern; Loren Peña; Brittany Smith; Tiina Urv; Charles Venditti; Anupam Chakarapani; Andrea L Gropman
Journal:  Mol Genet Metab       Date:  2011-10-19       Impact factor: 4.797

Review 3.  The screening and diagnosis of autistic spectrum disorders.

Authors:  P A Filipek; P J Accardo; G T Baranek; E H Cook; G Dawson; B Gordon; J S Gravel; C P Johnson; R J Kallen; S E Levy; N J Minshew; S Ozonoff; B M Prizant; I Rapin; S J Rogers; W L Stone; S Teplin; R F Tuchman; F R Volkmar
Journal:  J Autism Dev Disord       Date:  1999-12

Review 4.  Methylmalonic and propionic acidaemias: management and outcome.

Authors:  H Ogier de Baulny; J F Benoist; O Rigal; G Touati; D Rabier; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

5.  Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl.

Authors:  Işik Görker; Umran Tüzün
Journal:  J Psychiatry Neurosci       Date:  2005-03       Impact factor: 6.186

6.  Autism spectrum phenotype in males and females with fragile X full mutation and premutation.

Authors:  Sally Clifford; Cheryl Dissanayake; Quang M Bui; Richard Huggins; Annette K Taylor; Danuta Z Loesch
Journal:  J Autism Dev Disord       Date:  2007-04

7.  Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders.

Authors:  Derrick F MacFabe; Donald P Cain; Karina Rodriguez-Capote; Andrew E Franklin; Jennifer E Hoffman; Francis Boon; A Roy Taylor; Martin Kavaliers; Klaus-Peter Ossenkopp
Journal:  Behav Brain Res       Date:  2006-09-01       Impact factor: 3.332

Review 8.  Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults.

Authors:  F Sedel; N Baumann; J-C Turpin; O Lyon-Caen; J-M Saudubray; D Cohen
Journal:  J Inherit Metab Dis       Date:  2007-08-10       Impact factor: 4.982

9.  Adult outcome for children with autism.

Authors:  Patricia Howlin; Susan Goode; Jane Hutton; Michael Rutter
Journal:  J Child Psychol Psychiatry       Date:  2004-02       Impact factor: 8.982

10.  Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders.

Authors:  G Bradley Schaefer; Richard E Lutz
Journal:  Genet Med       Date:  2006-09       Impact factor: 8.822

View more
  18 in total

1.  A new opportunity: metabolism and neuropsychiatric disorders.

Authors:  Tamas Kozicz; E Morava
Journal:  J Inherit Metab Dis       Date:  2018-07       Impact factor: 4.982

2.  Impaired Spatial Cognition in Adult Rats Treated with Multiple Intracerebroventricular (ICV) Infusions of the Enteric Bacterial Metabolite, Propionic Acid, and Return to Baseline After 1 Week of No Treatment: Contribution to a Rodent Model of ASD.

Authors:  Jennifer R Mepham; Francis H Boon; Kelly A Foley; Donald P Cain; Derrick F MacFabe; Klaus-Peter Ossenkopp
Journal:  Neurotox Res       Date:  2019-03-08       Impact factor: 3.911

3.  Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision.

Authors:  Patrick Forny; Friederike Hörster; Diana Ballhausen; Anupam Chakrapani; Kimberly A Chapman; Carlo Dionisi-Vici; Marjorie Dixon; Sarah C Grünert; Stephanie Grunewald; Goknur Haliloglu; Michel Hochuli; Tomas Honzik; Daniela Karall; Diego Martinelli; Femke Molema; Jörn Oliver Sass; Sabine Scholl-Bürgi; Galit Tal; Monique Williams; Martina Huemer; Matthias R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2021-03-09       Impact factor: 4.750

4.  An overview of the Prince Salman Center for Disability Research scientific outcomes.

Authors:  Ali N Al-Odaib; Sultan T Al-Sedairy
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

5.  Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.

Authors:  Richard E Frye; Shannon Rose; John Slattery; Derrick F MacFabe
Journal:  Microb Ecol Health Dis       Date:  2015-05-07

Review 6.  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Authors:  Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams
Journal:  Front Public Health       Date:  2013-09-13

7.  Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model.

Authors:  Jane C Naviaux; Lin Wang; Kefeng Li; A Taylor Bright; William A Alaynick; Kenneth R Williams; Susan B Powell; Robert K Naviaux
Journal:  Mol Autism       Date:  2015-01-13       Impact factor: 7.509

8.  Audit of Organic Acidurias from a Single Centre: Clinical and Metabolic Profile at Presentation with Long Term Outcome.

Authors:  Seema Pavaman Sindgikar; Krithika Damodar Shenoy; Nutan Kamath; Rathika Shenoy
Journal:  J Clin Diagn Res       Date:  2017-09-01

9.  Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.

Authors:  R E Frye; S Melnyk; D F Macfabe
Journal:  Transl Psychiatry       Date:  2013-01-22       Impact factor: 6.222

10.  Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner.

Authors:  Kelly A Foley; Klaus-Peter Ossenkopp; Martin Kavaliers; Derrick F Macfabe
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.